Positive Topline Results from Phase 3 Trial of Evinacumab in Patients with Severe, Inherited Form of High Cholesterol Regeneron, August 14, 2019

Main|Search|PHGKB




Last Posted: Aug 17, 2019

---

• Positive Topline Results from Phase 3 Trial of Evinacumab in Patients with Severe, Inherited Form of High Cholesterol
  Regeneron, August 14, 2019
• Effects of familial hypercholesterolemia-associated genes on the phenotype of premature myocardial infarction.
  Lee Chongyou et al. Lipids in health and disease 2019 Apr 18(1) 95
• Twitter Helps Raise Awareness of Familial Hypercholesterolemia
  A Sheldon, The FH Foundation, August 13, 2019
• Screening and management of familial hypercholesterolemia.
  Santos Raul D et al. Current opinion in cardiology 2019 Sep (5) 526-530
• FH Optimal Care in the US (FOCUS) Real-World Data Analysis Report – 2018
  The FH Foundation, 2019
• Assessment of family physicians' awareness and knowledge of familial hypercholesterolemia in governmental hospitals in Riyadh, Saudi Arabia.
  Arnous Maha Mohammed et al. Journal of family medicine and primary care 2019 Jun 8(6) 1981-1986
• Incidence of Cardiovascular Disease in Patients with Familial Hypercholesterolemia Phenotype: Analysis of 5 Years Follow-Up of Real-World Data from More than 1.5 Million Patients.
  Masana Luís et al. Journal of clinical medicine 2019 Jul 8(7)
• Polygenic Risk Scores in Familial Hypercholesterolemia.
  Rader Daniel J et al. Journal of the American College of Cardiology 2019 Jul 74(4) 523-525
• Risk of Premature Atherosclerotic Disease in Patients With Monogenic Versus Polygenic Familial Hypercholesterolemia.
  Trinder Mark et al. Journal of the American College of Cardiology 2019 Jul 74(4) 512-522
• Prevalence, risk factor burden, and severity of coronary artery disease in patients with heterozygous familial hypercholesterolemia hospitalized for an acute myocardial infarction: Data from the French RICO survey.
  Farnier Michel et al. Journal of clinical lipidology 2019 Jun

more